Kidney Function Tests: Creatinine, GFR, and Urinalysis Explained
Learn how creatinine, eGFR, and urinalysis tests detect early kidney damage before symptoms appear. Understand what your numbers mean and how to protect your kidney health.
InternationalDrugMart.com - Your Global Pharmaceuticals Resource - Page 5
Type A vs Type B Adverse Drug Reactions: A Clear Guide to Predictable and Unpredictable Side Effects
Understand the difference between Type A and Type B adverse drug reactions-predictable side effects versus rare, dangerous idiosyncratic reactions. Learn how to recognize, manage, and prevent them.
Border and Customs Rules for Bringing Medications Internationally in 2025
Learn the 2025 rules for bringing prescription and controlled medications across international borders. Avoid seizures, fines, or detention with step-by-step documentation tips for the U.S., EU, Japan, UAE, and more.
Levodopa and Antipsychotics: How Opposing Dopamine Effects Worsen Symptoms
Levodopa and antipsychotics have opposing effects on dopamine, making it dangerous to use them together. This article explains how this interaction worsens Parkinson’s symptoms and psychosis, and what safer treatment options exist.
Fentanyl Patch Side Effects: Overdose and Withdrawal Risks Explained
Fentanyl patches are powerful but dangerous. Learn the real risks of overdose and withdrawal, how to use them safely, and what to do if you need to stop.
Corticosteroid Taper: How to Minimize Withdrawal Symptoms Safely
Learn how to safely taper off corticosteroids like prednisone to avoid withdrawal symptoms, protect your adrenal function, and prevent disease flares. Evidence-based strategies for a smoother transition.
Shortage Predictions: Forecasting Future Drug Scarcity 2025-2030
Drug shortages are worsening due to global supply chain fragility, manufacturing concentration, and economic pressures. By 2030, shortages of essential medicines could become routine without systemic reform.
Priority vs Standard Review: How FDA Prioritizes Generic Drug Applications
The FDA uses priority and standard review timelines to speed up access to generic drugs. Priority review cuts approval time to 8 months for first generics, shortage drugs, or improved formulations. A new pilot program rewards U.S. manufacturing with faster reviews.
Global Biosimilar Markets: Europe vs United States - How Regulations and Adoption Diverge
Europe led the world in biosimilar adoption with clear regulations and high uptake. The US lagged due to patents and strict rules-but is now accelerating fast. Here's how the two markets compare today and where they're headed.
Long-Acting Injectables: Why Extended Side Effect Monitoring Is Non-Negotiable
Long-acting injectable antipsychotics improve adherence but carry serious physical side effects. Without consistent monitoring, risks like diabetes, movement disorders, and metabolic syndrome go undetected - putting patients in danger.